English

MOLECULAR DEVICES CORP

EDGAR

Annual report (10-K) · filed 2007-03-16

48 filing records in this dataset, filed from 1996-08-14 to 2007-03-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

53.5 million USD

2006-12-31 · USD

Exact inputs and evidence

Revenue: 186412000 USD Source
Revenue: 132892000 USD Source

Operating margin

13.39%

2006-12-31 · %

Exact inputs and evidence

Operating Income: 16556000 USD Source
Operating Income: 9387000 USD Source
Revenue: 186412000 USD Source
Revenue: 132892000 USD Source

Operating cash flow

8.34 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 21703000 USD Source
Operating Cash Flow: 13360000 USD Source

Free cash flow

7.14 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 21703000 USD Source
Operating Cash Flow: 13360000 USD Source
Capital Expenditure: 5054000 USD Source
Capital Expenditure: 3850000 USD Source

Cash and cash equivalents: 22.8 million USD 2006-12-31 Source
Exact value

22824000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

186 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Revenue: 39996000 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 47385000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 45512000 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 186412000 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 132892000 USD · 2006-01-01 – 2006-09-30 Source

Net income

10.8 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Net income: 2846000 USD · 2006-01-01 – 2006-03-31 Source
Net income: -458000 USD · 2006-04-01 – 2006-06-30 Source
Net income: 2782000 USD · 2006-07-01 – 2006-09-30 Source
Net income: 10827000 USD · 2006-01-01 – 2006-12-31 Source
Net income: 5169000 USD · 2006-01-01 – 2006-09-30 Source

Operating cash flow

21.7 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: 3095000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 8662000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 3095000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 13360000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 8662000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 21703000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: 13360000 USD · 2006-01-01 – 2006-09-30 Source

Capital expenditure

5.05 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Capital expenditure: 737000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2441000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 737000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 3850000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 2441000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 5054000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 3850000 USD · 2006-01-01 – 2006-09-30 Source

Free cash flow

16.6 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: 3095000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 8662000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 3095000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 13360000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 8662000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 21703000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: 13360000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 737000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2441000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 737000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 3850000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 2441000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 5054000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 3850000 USD · 2006-01-01 – 2006-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-03-16.

Financial data available through: 2006-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2006-12-31
Operating income: 11 of 11 periods available· newest 2006-12-31
Net income: 11 of 11 periods available· newest 2006-12-31
Operating cash flow: 11 of 11 periods available· newest 2006-12-31
Capital expenditure: 11 of 11 periods available· newest 2006-12-31
Total assets: 11 of 11 periods available· newest 2006-12-31
Total liabilities: 4 of 11 periods available· newest 2006-12-31
Current assets: 11 of 11 periods available· newest 2006-12-31
Current liabilities: 11 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2.5%

Prior period

USD 181.95 million

2005-01-01 – 2005-12-31
Current period

USD 186.41 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

186412000 − 181951000 = 4461000 USD

181951000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
186412000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Year-over-year change in Revenue: 4461000 USD Concept: fundies:Revenue Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 186412000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#14576 Input fundies:Revenue: 181951000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#14576
The citation records this snapshot. The page link may show a newer release later.
Net income
-31.9%

Prior period

USD 15.9 million

2005-01-01 – 2005-12-31
Current period

USD 10.83 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

10827000 − 15896000 = -5069000 USD

15896000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
10827000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Year-over-year change in Net income: -5069000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 10827000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16542 Input fundies:NetIncome: 15896000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16542
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-11.8%

Prior period

USD 24.62 million

2005-01-01 – 2005-12-31
Current period

USD 21.7 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

21703000 − 24617000 = -2914000 USD

24617000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
21703000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Year-over-year change in Operating cash flow: -2914000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 21703000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 Input fundies:OperatingCashFlow: 24617000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+77.3%

Prior period

USD 2.85 million

2005-01-01 – 2005-12-31
Current period

USD 5.05 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

5054000 − 2850000 = 2204000 USD

2850000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
5054000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Year-over-year change in Capital expenditure: 2204000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5054000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 Input fundies:CapitalExpenditure: 2850000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2006-01-01 – 2006-12-31

Revenue USD 186.41 million 100% of revenue
Cost of revenue USD 70.07 million 38% of revenue
Operating expenses USD 99.79 million 54% of revenue
Operating income USD 16.56 million 8.9% of revenue
Tax, interest and other Derived USD 5.73 million 3.1% of revenue
Net income USD 10.83 million 5.8% of revenue

Cash

Operating cash flow USD 21.7 million 12% of revenue
Capital expenditure USD 5.05 million 2.7% of revenue
Free cash flow Derived USD 16.65 million 8.9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 14%81%
1998 Net income was higher than operating income, so the split is not drawn.
1999 95%
2000 Operating loss: operating costs were 104% of revenue.
2001 Operating loss: operating costs were 105% of revenue.
2002 92%
2003 91%
2004 Net income was higher than operating income, so the split is not drawn.
2005 86%
2006 91%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1997-01-01 – 1997-12-31	38286000	31030000 Derived	7256000	1954000 Derived	5302000	3786000 Derived	Source 1997-01-01 – 1997-12-31: 38286000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 7256000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: 5302000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 4411000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 625000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	52234000	51623000 Derived	611000	-1222000 Derived	1833000	-3201000 Derived	Source 1998-01-01 – 1998-12-31: 52234000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 611000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 1833000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -1187000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2014000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	71902000	68116000 Derived	3786000	135000 Derived	3651000	-6364000 Derived	Source 1999-01-01 – 1999-12-31: 71902000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 3786000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 3651000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -4371000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1993000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	96035000	99466000 Derived	-3431000	1503000 Derived	-4934000	-14576000 Derived	Source 2000-01-01 – 2000-12-31: 96035000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -3431000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -4934000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -7140000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 7436000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	92231000	96649000 Derived	-4418000	819000 Derived	-5237000	9989000 Derived	Source 2001-01-01 – 2001-12-31: 92231000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -4418000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -5237000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 13773000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 3784000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	102157000	93998000 Derived	8159000	1354000 Derived	6805000	12967000 Derived	Source 2002-01-01 – 2002-12-31: 102157000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 8159000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 6805000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 15262000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 2295000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	115581000	105392000 Derived	10189000	2447000 Derived	7742000	16348000 Derived	Source 2003-01-01 – 2003-12-31: 115581000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 10189000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 7742000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 18747000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 2399000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	149095000	137504000 Derived	11591000	-5642000 Derived	17233000	18366000 Derived	Source 2004-01-01 – 2004-12-31: 149095000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 11591000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 17233000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 23139000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 4773000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	181951000	156860000 Derived	25091000	9195000 Derived	15896000	21767000 Derived	Source 2005-01-01 – 2005-12-31: 181951000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 25091000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 15896000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 24617000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2850000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	186412000	169856000 Derived	16556000	5729000 Derived	10827000	16649000 Derived	Source 2006-01-01 – 2006-12-31: 186412000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 16556000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 10827000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 21703000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 5054000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 186.4M 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Revenue	38286000	Revenue: 38286000 Open source
19981998-12-31	Revenue	52234000	Revenue: 52234000 Open source
19991999-12-31	Revenue	71902000	Revenue: 71902000 Open source
20002000-12-31	Revenue	96035000	Revenue: 96035000 Open source
20012001-12-31	Revenue	92231000	Revenue: 92231000 Open source
20022002-12-31	Revenue	102157000	Revenue: 102157000 Open source
20032003-12-31	Revenue	115581000	Revenue: 115581000 Open source
20042004-12-31	Revenue	149095000	Revenue: 149095000 Open source
20052005-12-31	Revenue	181951000	Revenue: 181951000 Open source
20062006-12-31	Revenue	186412000	Revenue: 186412000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2.5% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Year over year	23.8%	Revenue: 38286000 Open source Revenue: 30926000 Open source
19981998-12-31	Year over year	36.4%	Revenue: 52234000 Open source Revenue: 38286000 Open source
19991999-12-31	Year over year	37.7%	Revenue: 71902000 Open source Revenue: 52234000 Open source
20002000-12-31	Year over year	33.6%	Revenue: 96035000 Open source Revenue: 71902000 Open source
20012001-12-31	Year over year	-4%	Revenue: 92231000 Open source Revenue: 96035000 Open source
20022002-12-31	Year over year	10.8%	Revenue: 102157000 Open source Revenue: 92231000 Open source
20032003-12-31	Year over year	13.1%	Revenue: 115581000 Open source Revenue: 102157000 Open source
20042004-12-31	Year over year	29%	Revenue: 149095000 Open source Revenue: 115581000 Open source
20052005-12-31	Year over year	22%	Revenue: 181951000 Open source Revenue: 149095000 Open source
20062006-12-31	Year over year	2.5%	Revenue: 186412000 Open source Revenue: 181951000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 8.9% 2006

Net margin 5.8% 2006

Free cash flow margin 8.9% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Operating margin	19%	Operating Income: 7256000 Open source Revenue: 38286000 Open source
19981998-12-31	Operating margin	1.2%	Operating Income: 611000 Open source Revenue: 52234000 Open source
19991999-12-31	Operating margin	5.3%	Operating Income: 3786000 Open source Revenue: 71902000 Open source
20002000-12-31	Operating margin	-3.6%	Operating Income: -3431000 Open source Revenue: 96035000 Open source
20012001-12-31	Operating margin	-4.8%	Operating Income: -4418000 Open source Revenue: 92231000 Open source
20022002-12-31	Operating margin	8%	Operating Income: 8159000 Open source Revenue: 102157000 Open source
20032003-12-31	Operating margin	8.8%	Operating Income: 10189000 Open source Revenue: 115581000 Open source
20042004-12-31	Operating margin	7.8%	Operating Income: 11591000 Open source Revenue: 149095000 Open source
20052005-12-31	Operating margin	13.8%	Operating Income: 25091000 Open source Revenue: 181951000 Open source
20062006-12-31	Operating margin	8.9%	Operating Income: 16556000 Open source Revenue: 186412000 Open source
19971997-12-31	Net margin	13.8%	Net Income: 5302000 Open source Revenue: 38286000 Open source
19981998-12-31	Net margin	3.5%	Net Income: 1833000 Open source Revenue: 52234000 Open source
19991999-12-31	Net margin	5.1%	Net Income: 3651000 Open source Revenue: 71902000 Open source
20002000-12-31	Net margin	-5.1%	Net Income: -4934000 Open source Revenue: 96035000 Open source
20012001-12-31	Net margin	-5.7%	Net Income: -5237000 Open source Revenue: 92231000 Open source
20022002-12-31	Net margin	6.7%	Net Income: 6805000 Open source Revenue: 102157000 Open source
20032003-12-31	Net margin	6.7%	Net Income: 7742000 Open source Revenue: 115581000 Open source
20042004-12-31	Net margin	11.6%	Net Income: 17233000 Open source Revenue: 149095000 Open source
20052005-12-31	Net margin	8.7%	Net Income: 15896000 Open source Revenue: 181951000 Open source
20062006-12-31	Net margin	5.8%	Net Income: 10827000 Open source Revenue: 186412000 Open source
19971997-12-31	Free cash flow margin	9.9%	Revenue: 38286000 Open source Operating Cash Flow: 4411000 Open source Capital Expenditure: 625000 Open source
19981998-12-31	Free cash flow margin	-6.1%	Revenue: 52234000 Open source Operating Cash Flow: -1187000 Open source Capital Expenditure: 2014000 Open source
19991999-12-31	Free cash flow margin	-8.9%	Revenue: 71902000 Open source Operating Cash Flow: -4371000 Open source Capital Expenditure: 1993000 Open source
20002000-12-31	Free cash flow margin	-15.2%	Revenue: 96035000 Open source Operating Cash Flow: -7140000 Open source Capital Expenditure: 7436000 Open source
20012001-12-31	Free cash flow margin	10.8%	Revenue: 92231000 Open source Operating Cash Flow: 13773000 Open source Capital Expenditure: 3784000 Open source
20022002-12-31	Free cash flow margin	12.7%	Revenue: 102157000 Open source Operating Cash Flow: 15262000 Open source Capital Expenditure: 2295000 Open source
20032003-12-31	Free cash flow margin	14.1%	Revenue: 115581000 Open source Operating Cash Flow: 18747000 Open source Capital Expenditure: 2399000 Open source
20042004-12-31	Free cash flow margin	12.3%	Revenue: 149095000 Open source Operating Cash Flow: 23139000 Open source Capital Expenditure: 4773000 Open source
20052005-12-31	Free cash flow margin	12%	Revenue: 181951000 Open source Operating Cash Flow: 24617000 Open source Capital Expenditure: 2850000 Open source
20062006-12-31	Free cash flow margin	8.9%	Revenue: 186412000 Open source Operating Cash Flow: 21703000 Open source Capital Expenditure: 5054000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 21.7M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Operating cash flow	4411000	Operating Cash Flow: 4411000 Open source
19981998-12-31	Operating cash flow	-1187000	Operating Cash Flow: -1187000 Open source
19991999-12-31	Operating cash flow	-4371000	Operating Cash Flow: -4371000 Open source
20002000-12-31	Operating cash flow	-7140000	Operating Cash Flow: -7140000 Open source
20012001-12-31	Operating cash flow	13773000	Operating Cash Flow: 13773000 Open source
20022002-12-31	Operating cash flow	15262000	Operating Cash Flow: 15262000 Open source
20032003-12-31	Operating cash flow	18747000	Operating Cash Flow: 18747000 Open source
20042004-12-31	Operating cash flow	23139000	Operating Cash Flow: 23139000 Open source
20052005-12-31	Operating cash flow	24617000	Operating Cash Flow: 24617000 Open source
20062006-12-31	Operating cash flow	21703000	Operating Cash Flow: 21703000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 16.6M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Free cash flow	3786000	Operating Cash Flow: 4411000 Open source Capital Expenditure: 625000 Open source
19981998-12-31	Free cash flow	-3201000	Operating Cash Flow: -1187000 Open source Capital Expenditure: 2014000 Open source
19991999-12-31	Free cash flow	-6364000	Operating Cash Flow: -4371000 Open source Capital Expenditure: 1993000 Open source
20002000-12-31	Free cash flow	-14576000	Operating Cash Flow: -7140000 Open source Capital Expenditure: 7436000 Open source
20012001-12-31	Free cash flow	9989000	Operating Cash Flow: 13773000 Open source Capital Expenditure: 3784000 Open source
20022002-12-31	Free cash flow	12967000	Operating Cash Flow: 15262000 Open source Capital Expenditure: 2295000 Open source
20032003-12-31	Free cash flow	16348000	Operating Cash Flow: 18747000 Open source Capital Expenditure: 2399000 Open source
20042004-12-31	Free cash flow	18366000	Operating Cash Flow: 23139000 Open source Capital Expenditure: 4773000 Open source
20052005-12-31	Free cash flow	21767000	Operating Cash Flow: 24617000 Open source Capital Expenditure: 2850000 Open source
20062006-12-31	Free cash flow	16649000	Operating Cash Flow: 21703000 Open source Capital Expenditure: 5054000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

18.3% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-12-31	Liabilities / assets	Not reported	Total Assets: 42791000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 54405000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 86849000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 180033000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 152361000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 162901000 Open source
20032003-12-31	Liabilities / assets	12.8%	Total Liabilities: 21375000 Open source Total Assets: 166913000 Open source
20042004-12-31	Liabilities / assets	17.5%	Total Liabilities: 44609000 Open source Total Assets: 255229000 Open source
20052005-12-31	Liabilities / assets	17.2%	Total Liabilities: 44343000 Open source Total Assets: 257416000 Open source
20062006-12-31	Liabilities / assets	18.3%	Total Liabilities: 48792000 Open source Total Assets: 266778000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.54× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Current assets / current liabilities	7.65×	Current Assets: 41126000 Open source Current Liabilities: 5374000 Open source
19981998-12-31	Current assets / current liabilities	6.06×	Current Assets: 52020000 Open source Current Liabilities: 8582000 Open source
19991999-12-31	Current assets / current liabilities	6.5×	Current Assets: 77707000 Open source Current Liabilities: 11959000 Open source
20002000-12-31	Current assets / current liabilities	9.57×	Current Assets: 154315000 Open source Current Liabilities: 16131000 Open source
20012001-12-31	Current assets / current liabilities	7.68×	Current Assets: 114298000 Open source Current Liabilities: 14876000 Open source
20022002-12-31	Current assets / current liabilities	5.22×	Current Assets: 104948000 Open source Current Liabilities: 20097000 Open source
20032003-12-31	Current assets / current liabilities	5.08×	Current Assets: 108680000 Open source Current Liabilities: 21375000 Open source
20042004-12-31	Current assets / current liabilities	2.79×	Current Assets: 105389000 Open source Current Liabilities: 37833000 Open source
20052005-12-31	Current assets / current liabilities	2.61×	Current Assets: 101528000 Open source Current Liabilities: 38864000 Open source
20062006-12-31	Current assets / current liabilities	2.54×	Current Assets: 99578000 Open source Current Liabilities: 39162000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1997-01-01 – 1997-12-31	USD 5.3 million Exact value Exact value: 5302000 USD 1997-01-01 – 1997-12-31: 5302000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 1997-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 5302000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5302000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-00-001772.txt#2502 The citation records this snapshot. The page link may show a newer release later.	USD 4.41 million Exact value Exact value: 4411000 USD 1997-01-01 – 1997-12-31: 4411000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 1997-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 4411000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4411000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-00-001772.txt#2521 The citation records this snapshot. The page link may show a newer release later.	USD 625,000 Exact value Exact value: 625000 USD 1997-01-01 – 1997-12-31: 625000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 1997-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 625000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 625000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-00-001772.txt#2524 The citation records this snapshot. The page link may show a newer release later.	USD 3.79 million Calculation and evidence 4411000 − 625000 USD Exact free cash flow: 3786000 USD 1997-01-01 – 1997-12-31: 4411000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 625000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 1997-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 3786000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4411000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-00-001772.txt#2521 Input fundies:CapitalExpenditure: 625000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-00-001772.txt#2524 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 1.83 million Exact value Exact value: 1833000 USD 1998-01-01 – 1998-12-31: 1833000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 1998-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 1833000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1833000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-01-000257.txt#2911 The citation records this snapshot. The page link may show a newer release later.	−USD 1.19 million Exact value Exact value: -1187000 USD 1998-01-01 – 1998-12-31: -1187000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 1998-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: -1187000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1187000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-01-000257.txt#2931 The citation records this snapshot. The page link may show a newer release later.	USD 2.01 million Exact value Exact value: 2014000 USD 1998-01-01 – 1998-12-31: 2014000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 1998-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 2014000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2014000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-01-000257.txt#2937 The citation records this snapshot. The page link may show a newer release later.	−USD 3.2 million Calculation and evidence -1187000 − 2014000 USD Exact free cash flow: -3201000 USD 1998-01-01 – 1998-12-31: -1187000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2014000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 1998-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: -3201000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1187000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-01-000257.txt#2931 Input fundies:CapitalExpenditure: 2014000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-01-000257.txt#2937 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 3.65 million Exact value Exact value: 3651000 USD 1999-01-01 – 1999-12-31: 3651000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 1999-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 3651000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3651000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-02-001604.txt#9388 The citation records this snapshot. The page link may show a newer release later.	−USD 4.37 million Exact value Exact value: -4371000 USD 1999-01-01 – 1999-12-31: -4371000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 1999-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: -4371000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4371000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-02-001604.txt#9693 The citation records this snapshot. The page link may show a newer release later.	USD 1.99 million Exact value Exact value: 1993000 USD 1999-01-01 – 1999-12-31: 1993000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 1999-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 1993000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1993000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-02-001604.txt#9771 The citation records this snapshot. The page link may show a newer release later.	−USD 6.36 million Calculation and evidence -4371000 − 1993000 USD Exact free cash flow: -6364000 USD 1999-01-01 – 1999-12-31: -4371000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1993000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 1999-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: -6364000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4371000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-02-001604.txt#9693 Input fundies:CapitalExpenditure: 1993000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-02-001604.txt#9771 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 4.93 million Exact value Exact value: -4934000 USD 2000-01-01 – 2000-12-31: -4934000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2000-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: -4934000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4934000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-03-001472.txt#10214 The citation records this snapshot. The page link may show a newer release later.	−USD 7.14 million Exact value Exact value: -7140000 USD 2000-01-01 – 2000-12-31: -7140000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2000-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: -7140000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7140000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-03-001472.txt#10535 The citation records this snapshot. The page link may show a newer release later.	USD 7.44 million Exact value Exact value: 7436000 USD 2000-01-01 – 2000-12-31: 7436000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2000-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 7436000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7436000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-03-001472.txt#10613 The citation records this snapshot. The page link may show a newer release later.	−USD 14.58 million Calculation and evidence -7140000 − 7436000 USD Exact free cash flow: -14576000 USD 2000-01-01 – 2000-12-31: -7140000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 7436000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2000-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: -14576000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7140000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-03-001472.txt#10535 Input fundies:CapitalExpenditure: 7436000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-03-001472.txt#10613 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 5.24 million Exact value Exact value: -5237000 USD 2001-01-01 – 2001-12-31: -5237000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2001-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: -5237000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5237000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-04-000683.txt#11337 The citation records this snapshot. The page link may show a newer release later.	USD 13.77 million Exact value Exact value: 13773000 USD 2001-01-01 – 2001-12-31: 13773000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2001-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 13773000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 13773000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-04-000683.txt#11710 The citation records this snapshot. The page link may show a newer release later.	USD 3.78 million Exact value Exact value: 3784000 USD 2001-01-01 – 2001-12-31: 3784000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2001-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 3784000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3784000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-04-000683.txt#11797 The citation records this snapshot. The page link may show a newer release later.	USD 9.99 million Calculation and evidence 13773000 − 3784000 USD Exact free cash flow: 9989000 USD 2001-01-01 – 2001-12-31: 13773000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 3784000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2001-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 9989000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13773000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-04-000683.txt#11710 Input fundies:CapitalExpenditure: 3784000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000891618-04-000683.txt#11797 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	USD 6.81 million Exact value Exact value: 6805000 USD 2002-01-01 – 2002-12-31: 6805000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2002-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 6805000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6805000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-05-005265.txt#13231 The citation records this snapshot. The page link may show a newer release later.	USD 15.26 million Exact value Exact value: 15262000 USD 2002-01-01 – 2002-12-31: 15262000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2002-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 15262000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15262000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-05-005265.txt#13668 The citation records this snapshot. The page link may show a newer release later.	USD 2.3 million Exact value Exact value: 2295000 USD 2002-01-01 – 2002-12-31: 2295000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2002-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 2295000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2295000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-05-005265.txt#13779 The citation records this snapshot. The page link may show a newer release later.	USD 12.97 million Calculation and evidence 15262000 − 2295000 USD Exact free cash flow: 12967000 USD 2002-01-01 – 2002-12-31: 15262000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 2295000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2002-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 12967000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15262000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-05-005265.txt#13668 Input fundies:CapitalExpenditure: 2295000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-05-005265.txt#13779 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 7.74 million Exact value Exact value: 7742000 USD 2003-01-01 – 2003-12-31: 7742000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2003-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 7742000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7742000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-06-005275.txt#22746 The citation records this snapshot. The page link may show a newer release later.	USD 18.75 million Exact value Exact value: 18747000 USD 2003-01-01 – 2003-12-31: 18747000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2003-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 18747000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 18747000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-06-005275.txt#23717 The citation records this snapshot. The page link may show a newer release later.	USD 2.4 million Exact value Exact value: 2399000 USD 2003-01-01 – 2003-12-31: 2399000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2003-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 2399000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2399000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-06-005275.txt#23984 The citation records this snapshot. The page link may show a newer release later.	USD 16.35 million Calculation and evidence 18747000 − 2399000 USD Exact free cash flow: 16348000 USD 2003-01-01 – 2003-12-31: 18747000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 2399000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2003-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 16348000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 18747000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-06-005275.txt#23717 Input fundies:CapitalExpenditure: 2399000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-06-005275.txt#23984 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	USD 17.23 million Exact value Exact value: 17233000 USD 2004-01-01 – 2004-12-31: 17233000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2004-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 17233000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 17233000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16542 The citation records this snapshot. The page link may show a newer release later.	USD 23.14 million Exact value Exact value: 23139000 USD 2004-01-01 – 2004-12-31: 23139000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2004-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 23139000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23139000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 The citation records this snapshot. The page link may show a newer release later.	USD 4.77 million Exact value Exact value: 4773000 USD 2004-01-01 – 2004-12-31: 4773000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2004-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 4773000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4773000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.	USD 18.37 million Calculation and evidence 23139000 − 4773000 USD Exact free cash flow: 18366000 USD 2004-01-01 – 2004-12-31: 23139000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 4773000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2004-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 18366000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23139000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 Input fundies:CapitalExpenditure: 4773000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 15.9 million Exact value Exact value: 15896000 USD 2005-01-01 – 2005-12-31: 15896000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2005-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 15896000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 15896000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16542 The citation records this snapshot. The page link may show a newer release later.	USD 24.62 million Exact value Exact value: 24617000 USD 2005-01-01 – 2005-12-31: 24617000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2005-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 24617000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24617000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 The citation records this snapshot. The page link may show a newer release later.	USD 2.85 million Exact value Exact value: 2850000 USD 2005-01-01 – 2005-12-31: 2850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2005-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 2850000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2850000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.	USD 21.77 million Calculation and evidence 24617000 − 2850000 USD Exact free cash flow: 21767000 USD 2005-01-01 – 2005-12-31: 24617000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2005-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 21767000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24617000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 Input fundies:CapitalExpenditure: 2850000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 10.83 million Exact value Exact value: 10827000 USD 2006-01-01 – 2006-12-31: 10827000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Net Income: 10827000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10827000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16542 The citation records this snapshot. The page link may show a newer release later.	USD 21.7 million Exact value Exact value: 21703000 USD 2006-01-01 – 2006-12-31: 21703000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Operating Cash Flow: 21703000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21703000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 The citation records this snapshot. The page link may show a newer release later.	USD 5.05 million Exact value Exact value: 5054000 USD 2006-01-01 – 2006-12-31: 5054000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Capital Expenditure: 5054000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5054000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.	USD 16.65 million Calculation and evidence 21703000 − 5054000 USD Exact free cash flow: 16649000 USD 2006-01-01 – 2006-12-31: 21703000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 5054000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR DEVICES CORP · 2006-12-31 MOLECULAR DEVICES CORP (edgar:1003113) Free cash flow: 16649000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T05:17:30Z Snapshot: 3b720bbfa018a337852c41ae71f307d7109fb7706e07b2509af1038aaba1e752 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003113?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21703000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16878 Input fundies:CapitalExpenditure: 5054000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003113/0000950134-07-005943.txt#16958 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001003113, 1003113, edgar:1003113

MOLECULAR DEVICES CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2006-01-01 – 2006-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation